816 related articles for article (PubMed ID: 18022078)
1. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
2. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
Burton CM; Iversen M; Carlsen J; Mortensen J; Andersen CB; Steinbrüchel D; Scheike T
J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040
[TBL] [Abstract][Full Text] [Related]
3. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome.
Burton CM; Carlsen J; Mortensen J; Andersen CB; Milman N; Iversen M
J Heart Lung Transplant; 2007 Jul; 26(7):681-6. PubMed ID: 17613397
[TBL] [Abstract][Full Text] [Related]
5. Primary graft dysfunction and long-term pulmonary function after lung transplantation.
Whitson BA; Prekker ME; Herrington CS; Whelan TP; Radosevich DM; Hertz MI; Dahlberg PS
J Heart Lung Transplant; 2007 Oct; 26(10):1004-11. PubMed ID: 17919620
[TBL] [Abstract][Full Text] [Related]
6. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
7. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
[TBL] [Abstract][Full Text] [Related]
8. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
[TBL] [Abstract][Full Text] [Related]
9. Impact of oropharyngeal dysphagia on long-term outcomes of lung transplantation.
Atkins BZ; Petersen RP; Daneshmand MA; Turek JW; Lin SS; Davis RD
Ann Thorac Surg; 2010 Nov; 90(5):1622-8. PubMed ID: 20971276
[TBL] [Abstract][Full Text] [Related]
10. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
[TBL] [Abstract][Full Text] [Related]
11. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.
Davis RD; Lau CL; Eubanks S; Messier RH; Hadjiliadis D; Steele MP; Palmer SM
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):533-42. PubMed ID: 12658195
[TBL] [Abstract][Full Text] [Related]
12. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients.
Hohlfeld J; Niedermeyer J; Hamm H; Schäfers HJ; Wagner TO; Fabel H
J Heart Lung Transplant; 1996 Sep; 15(9):888-94. PubMed ID: 8889984
[TBL] [Abstract][Full Text] [Related]
13. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the 6min walk test in bronchiolitis obliterans syndrome.
Nathan SD; Shlobin OA; Reese E; Ahmad S; Fregoso M; Athale C; Barnett SD
Respir Med; 2009 Dec; 103(12):1816-21. PubMed ID: 19682883
[TBL] [Abstract][Full Text] [Related]
15. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
[TBL] [Abstract][Full Text] [Related]
16. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
17. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
Liu V; Dhillon GS; Weill D
Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
[TBL] [Abstract][Full Text] [Related]
18. Single-lung transplantation: does side matter?
Tsagkaropoulos S; Belmans A; Verleden GM; Coosemans W; Decaluwe H; De Leyn P; Nafteux P; Van Raemdonck D
Eur J Cardiothorac Surg; 2011 Aug; 40(2):e83-92. PubMed ID: 21497108
[TBL] [Abstract][Full Text] [Related]
19. Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.
Munster JM; van der Bij W; Breukink MB; van der Steege G; Zuurman MW; Hepkema BG; Verschuuren EA; van Son WJ; Seelen MA
Transplantation; 2008 Dec; 86(12):1857-63. PubMed ID: 19104434
[TBL] [Abstract][Full Text] [Related]
20. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
Lama VN; Murray S; Lonigro RJ; Toews GB; Chang A; Lau C; Flint A; Chan KM; Martinez FJ
Am J Respir Crit Care Med; 2007 Jun; 175(11):1192-8. PubMed ID: 17347496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
